Wu Chuanliu
The MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, State Key Laboratory of Physical Chemistry of Solid Surfaces, Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.
Acc Chem Res. 2025 May 20;58(10):1620-1631. doi: 10.1021/acs.accounts.5c00060. Epub 2025 Mar 14.
ConspectusMulticyclic peptides that are constrained through covalent cross-linkers can usually maintain stable three-dimensional (3D) structures without the necessity of incorporating noncovalently interacting cores. This configuration allows for a greater utilization of residues for functional purposes compared to larger proteins, rendering multicyclic peptides attractive molecular modalities for the development of chemical tools and therapeutic agents. Even smaller multicyclic peptides, which may lack stable 3D structures due to limited sequence-driven folding capabilities, can still benefit from the specific conformations stabilized by covalent cross-linkers to facilitate target binding. Disulfide-rich peptides (DRPs) are a class of particularly significant multicyclic peptides that are primarily composed of disulfide bonds in their interior. However, the structural diversity of DRPs is limited to a few naturally occurring and designer scaffolds, which significantly impedes the development of multicyclic peptide ligands and therapeutics. To address this issue, we developed a novel method that utilizes disulfide-directing motifs to design and discover DRPs with new structures and functions in random sequence space. Compared with traditional DRPs, these new DRPs that incorporate disulfide-directing motifs exhibit more precise oxidative folding regarding disulfide pairing and demonstrate greater tolerance to sequence manipulations. Thus, we designated these peptides as disulfide-directed multicyclic peptides (DDMPs).Over the past decade, we have developed a new class of multicyclic peptides by leveraging disulfide-directing motifs, including biscysteine motifs such as CPXXC, CPPC, and CXC (C: cysteine; P: proline; X: any amino acid), as well as triscysteine motifs that rationally combine two biscysteine motifs (, CPPCXC and CPXXCXC) to direct the oxidative folding of peptides. This leads to the introduction of a novel concept known as motif-directed oxidative folding, which is valuable for the construction of peptides with multiple disulfide bonds. A large diversity of DDMPs have been designed by simply altering the disulfide-directing motifs, the arrangement of cysteine residues (, cysteine patterns), and the number of random residues separating them. As the oxidative folding of DDMPs is primarily determined by disulfide-directing motifs, these peptides are intrinsically more tolerant of extensive sequence manipulations compared to traditional DRPs. Consequently, multicyclic peptide libraries with an unprecedented high degree of sequence randomization have been developed by utilizing commonly used biological display systems such as phage display. We have validated the applicability of these libraries by successfully discovering DDMPs with unique protein-like 3D structures and high affinity and specificity to various cell-surface receptors, including tumor-associated antigens, immune costimulatory receptors, and G protein-coupled receptors (GPCRs). Currently, multicyclic peptides used in clinical settings are of natural origin or derived from natural DRPs. Our studies have opened up the possibility of developing multicyclic peptides without relying on natural scaffolds, representing a pivotal breakthrough in the field of peptide ligand and drug discovery. Further investigations will facilitate the application of our DDMPs in broader fields such as bioanalysis, chemical biology, and biomedicine.
概述
通过共价交联剂形成约束的多环肽通常能够维持稳定的三维(3D)结构,而无需引入非共价相互作用的核心。与较大的蛋白质相比,这种结构使得残基在功能用途上有更高的利用率,使多环肽成为开发化学工具和治疗药物的有吸引力的分子形式。即使是较小的多环肽,由于序列驱动的折叠能力有限可能缺乏稳定的3D结构,但仍然可以受益于由共价交联剂稳定的特定构象,以促进与靶标的结合。富含二硫键的肽(DRP)是一类特别重要的多环肽,其内部主要由二硫键组成。然而,DRP的结构多样性仅限于少数天然存在的和设计的支架,这严重阻碍了多环肽配体和治疗药物的开发。为了解决这个问题,我们开发了一种新方法,利用二硫键导向基序在随机序列空间中设计和发现具有新结构和功能的DRP。与传统的DRP相比,这些包含二硫键导向基序的新DRP在二硫键配对方面表现出更精确的氧化折叠,并且对序列操作具有更高的耐受性。因此,我们将这些肽命名为二硫键导向的多环肽(DDMP)。
在过去十年中,我们通过利用二硫键导向基序开发了一类新的多环肽,包括双半胱氨酸基序,如CPXXC、CPPC和CXC(C:半胱氨酸;P:脯氨酸;X:任何氨基酸),以及合理组合两个双半胱氨酸基序的三半胱氨酸基序(如CPPCXC和CPXXCXC)来指导肽的氧化折叠。这导致引入了一个称为基序导向氧化折叠的新概念,这对于构建具有多个二硫键的肽很有价值。通过简单地改变二硫键导向基序、半胱氨酸残基的排列(即半胱氨酸模式)以及分隔它们的随机残基数量,已经设计出了多种多样的DDMP。由于DDMP的氧化折叠主要由二硫键导向基序决定,与传统的DRP相比,这些肽在本质上对广泛的序列操作具有更高的耐受性。因此,通过利用常用的生物展示系统,如噬菌体展示,已经开发出了具有前所未有的高度序列随机性的多环肽文库。我们通过成功发现具有独特的类蛋白质3D结构以及对各种细胞表面受体,包括肿瘤相关抗原、免疫共刺激受体和G蛋白偶联受体(GPCR)具有高亲和力和特异性的DDMP,验证了这些文库的适用性。目前,临床应用中的多环肽是天然来源的或源自天然DRP。我们的研究开辟了不依赖天然支架开发多环肽的可能性,这代表了肽配体和药物发现领域的一个关键突破。进一步的研究将促进我们的DDMP在生物分析、化学生物学和生物医学等更广泛领域的应用。